Azenta, Inc.

By person

44 insiders · 276 transactions

5.8×

John Marotta holds 5.8 times base salary in stock. $5.25M of shares against $900.00K in salary for 2025.

Salary from the company's own proxy. The shares are what John Marotta last reported holding, valued at $24.17, the price Common was last bought or sold at on the open market here, on 31 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

SCHWARTZ STEPHEN S

CEO

—

$35.52M (42)

−$35.52M

446,536

1.02%

$10.79M

−38.0%

Robertson Lindon G

EVP & Chief Financial Officer

$250.65K (1)

$16.50M (25)

−$16.25M

121,081

0.2764%

$2.93M

−54.5%

Jarzynka David

President, Semi Solutions

—

$12.50M (25)

−$12.50M

46,315

0.1057%

$1.12M

−60.0%

Montone William T.

SVP, Human Resources

—

$8.22M (34)

−$8.22M

91,936

0.2099%

$2.22M

−49.7%

Joseph Jason

SVP, General Counsel, Secy.

—

$7.72M (39)

−$7.72M

112,564

0.2569%

$2.72M

−40.4%

Gray David C

Chief Strategy & New Business

—

$6.91M (28)

−$6.91M

74,868

0.1709%

$1.81M

−26.2%

Pietrantoni David

Principal Accounting Officer

—

$6.64M (35)

−$6.64M

27,375

0.0625%

$661.59K

−74.0%

Tenney Maurice H.

President-Brooks Life Sciences

—

$4.01M (12)

−$4.01M

136,556

0.3117%

$3.30M

−32.7%

Vacha Robin

SVP, GM Life Science Products

—

$2.28M (5)

−$2.28M

31,287

0.0714%

$756.13K

+103.1%

Cornog William L

Director

$658.80K (2)

—

+$658.80K

21,958

0.0501%

$530.67K

—

MARTIN JOSEPH R

Director

—

$554.11K (3)

−$554.11K

85,175

0.1944%

$2.06M

+24.1%

Marotta John

President and CEO

$552.90K (2)

$9.29K (1)

+$543.61K

217,269

0.4960%

$5.25M

—

McManus Matthew

EVP & Chief Operating Officer

$501.54K (1)

—

+$501.54K

29,467

0.0673%

$712.15K

+41.4%

Rosenblatt Michael

Director

—

$481.50K (2)

−$481.50K

13,042

0.0298%

$315.19K

—

WOOLLACOTT ALFRED III

Director

—

$333.64K (2)

−$333.64K

81,736

0.1866%

$1.98M

−6.2%

Madaus Martin D

Interim CEO

$201.40K (1)

—

+$201.40K

44,058

0.1006%

$1.06M

—

Liao Guojuan

President, GENEWIZ

—

$136.02K (2)

−$136.02K

12,827

0.0293%

$310.00K

—

Cueto Herman

EVP, Chief Financial Officer

—

$98.20K (2)

−$98.20K

23,892

0.0545%

$577.41K

—

Lin Lawrence Y.

EVP, CFO and Treasurer

$69.90K (1)

—

+$69.90K

110,199

0.2515%

$2.66M

+1,595%

Davis Robyn C

Director

—

$46.53K (1)

−$46.53K

33,627

0.0768%

$812.68K

+202.8%

HIRSCH DIDIER

Director

$39.50K (1)

—

+$39.50K

3,465

0.0079%

$83.74K

—

Hughes Violetta

VP, Chief Accounting Officer

—

$23.32K (2)

−$23.32K

9,603

0.0219%

$232.08K

+257.9%

Pirogova Olga

SVP and CHRO

—

$21.96K (1)

−$21.96K

47,225

0.1078%

$1.14M

—

De Jesus Linda

Chief Commercial Officer, LS

—

$19.59K (1)

−$19.59K

2,764

0.0063%

$66.80K

+109.4%

Wang David Dong

SVP & GM, SMS

—

$13.94K (1)

−$13.94K

23,974

0.0547%

$579.39K

+274.1%

Crowley Kimberly

SVP, Chief HR Officer

—

$10.30K (1)

−$10.30K

7,399

0.0169%

$178.82K

+82.1%

Starr Ephraim

SVP, Gen Counsel & Secretary

$8.10K (1)

—

+$8.10K

84,000

0.1917%

$2.03M

—

Zhou Ginger

SVP and GM, Multiomics

$19.13K (1)

$19.67K (1)

−$542.41

38,755

0.0885%

$936.62K

+668.0%

WRIGHTON MARK S

Director

—

111,818

0.2552%

$2.70M

+17.9%

Palepu Krishna G.

Director

—

105,393

0.2406%

$2.55M

+26.5%

ALLEN A CLINTON

Director

—

82,127

0.1875%

$1.98M

+19.2%

Zane Ellen M

Director

—

41,134

0.0939%

$994.11K

+8.7%

MARTIN WILLIAM E. III

President Multiomics

—

33,062

0.0755%

$799.03K

—

McLaughlin Erica

Director

—

22,521

0.0514%

$544.28K

—

Casal Frank

Director

—

21,803

0.0498%

$526.93K

—

Malus Alan J

Director

—

17,035

0.0389%

$411.70K

—

Nova Tina Susan

Director

—

15,772

0.0360%

$381.17K

+219.9%

Koffey Quentin

Director

—

10,698

0.0244%

$258.54K

—

Doshi Dipal

Director

—

9,703

0.0221%

$234.50K

—

Sriram Vandana

SVP Finance & Corp. Controller

—

6,356

0.0145%

$153.61K

+95.1%

Bello Erik J.

VP Chief Accounting Officer

—

4,586

0.0105%

$110.83K

—

PUHY DOROTHY E

Director

—

3,604

0.0082%

$87.10K

—

Bousa Edward Peter

Director

—

2,465

0.0056%

$59.57K

−50.0%

Coyne Mitchell

SVP and GM, Life Sciences Proj

—

1,889

0.0043%

$45.65K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Starr Ephraim

31 Jul 2026

SVP, Gen Counsel & Secretary

Buy

335

$24.17

$8.10K

Cornog William L

18 May 2026

Director

Buy indirect

10,000

$16.38

$163.80K

Lin Lawrence Y.

11 Aug 2025

EVP, CFO and Treasurer

Buy

2,500

$27.96

$69.90K

Zhou Ginger

31 Jan 2025

SVP and General Manager, Genom

Buy

417

$45.88

$19.13K

Madaus Martin D

19 Nov 2024

Director

Buy

4,940

$40.77

$201.40K

Marotta John

19 Nov 2024

President and CEO

Buy

1,250

$40.67

$50.84K

HIRSCH DIDIER

18 Nov 2024

Director

Buy

1,000

$39.50

$39.50K

Cornog William L

18 Nov 2024

Director

Buy indirect

12,500

$39.60

$495.00K

Marotta John

18 Nov 2024

President and CEO

Buy

12,717

$39.48

$502.07K

McManus Matthew

19 Aug 2022

EVP & Chief Operating Officer

Buy

8,625

$58.15

$501.54K

Robertson Lindon G

19 Aug 2022

EVP & Chief Financial Officer

Buy

4,350

$57.62

$250.65K

Showing 250 of 276 transactions. The figures above use every one of them.

By person

Individual transactions

What was left out